Morgan Stanley Finance LLC Files Pricing Supplement No. 14,799

TL;DR

**Morgan Stanley Finance LLC is issuing new securities, watch for potential impact on MS.**

AI Summary

Morgan Stanley Finance LLC, a subsidiary of Morgan Stanley, filed a 424B2 prospectus on March 24, 2026, related to its existing shelf registration (File No. 333-275587-01). This filing, specifically Pricing Supplement No. 14,799, indicates the offering of new securities under their previously approved registration statement. For investors, this means Morgan Stanley Finance LLC is actively raising capital, which could impact the company's debt levels and future earnings, potentially affecting the stock price of its parent company, Morgan Stanley.

Why It Matters

This filing signals Morgan Stanley Finance LLC is issuing new securities, which could alter its capital structure and potentially influence the financial health and stock performance of its parent, Morgan Stanley.

Risk Assessment

Risk Level: medium — The filing itself is routine, but the underlying offering of securities introduces market and credit risk for investors in those securities, and could impact the parent company's financials.

Analyst Insight

Investors should monitor subsequent filings or news from Morgan Stanley Finance LLC and Morgan Stanley for details on the specific securities offered in Pricing Supplement No. 14,799, including their terms, size, and intended use of proceeds, to assess potential impacts on the parent company's financial health and stock valuation.

Key Numbers

• 14,799 — Pricing Supplement Number (Identifies the specific terms of the securities being offered under the shelf registration.)
• 333-275587-01 — Shelf Registration File Number (Indicates the overarching registration statement under which these securities are being offered.)
• 2026-03-24 — Filing Date (The date the prospectus was filed with the SEC.)

Key Players & Entities

• Morgan Stanley Finance LLC (company) — Filer of the 424B2 prospectus
• Morgan Stanley (company) — Parent company of the filer
• 0001666268 (person) — CIK of Morgan Stanley Finance LLC
• 0000895421 (person) — CIK of Morgan Stanley
• 333-275587-01 (dollar_amount) — File number for Morgan Stanley Finance LLC's shelf registration
• 14,799 (dollar_amount) — Pricing Supplement Number
• 2026-03-24 (dollar_amount) — Filing Date

FAQ

Key Financial Figures

• $1,000 — an Stanley Stated principal amount: $1,000 per security Issue price: $1,000 pe
• $280,000 — below) Aggregate principal amount: $280,000 Underlier: The underlier is an unde
• $55.64 — rkets ETF (the "EEM Index") 33.333% $55.64 0.599083393 We refer to each of the
• $963.30 — Estimated value on the pricing date: $963.30 per security. See "Estimated Value of t
• $7.50 — eds to us (3) Per security $1,000 $7.50 $992.50 Total $280,000 $2,100
• $992.50 — s (3) Per security $1,000 $7.50 $992.50 Total $280,000 $2,100 $277,900
• $2,100 — $7.50 $992.50 Total $280,000 $2,100 $277,900 (1) The securities will be
• $277,900 — $992.50 Total $280,000 $2,100 $277,900 (1) The securities will be sold only
• $1,115 — appreciates 10%, investors will receive $1,115 per security, or 111.50% of the stated
• $350 — 65% of their principal and receive only $350 per security at maturity, or 35% of the

Filing Documents

• ms14799_424b2-10655.htm (424B2) — 221KB
• ex-filingfees.htm (EX-FILING FEES) — 8KB
• image1.gif (GRAPHIC) — 42KB
• image2.gif (GRAPHIC) — 78KB
• image3.gif (GRAPHIC) — 78KB
• image4.gif (GRAPHIC) — 78KB
• image5.gif (GRAPHIC) — 84KB
• 0001839882-26-016665.txt ( ) — 820KB
• ex-filingfees_htm.xml (XML) — 2KB

Risk Factors

Risk Factors This section describes the material risks relating to the securities. For further discussion of these and other risks, you should read the section entitled "Risk Factors" in the accompanying product supplement and prospectus. We also urge you to consult with your investment, legal, tax, accounting and other advisers in connection with your investment in the securities. Risks Relating to an Investment in the Securities The securities provide for only the minimum payment at maturity and do not pay interest. The terms of the securities differ from those of ordinary debt securities in that they provide for only the minimum payment at maturity and do not pay interest. If the final level is less than the buffer level, the payout at maturity will be an amount in cash that is less than the stated principal amount of each security, and you will lose an amount proportionate to the full decline in the level of the underlier over the term of the securities beyond the buffer amount. You could lose a significant portion of your initial investment in the securities. The amount payable on the securities is not linked to the value of the underlier at any time other than the observation date. The final level will be based on the closing level of the underlier on the observation date, subject to postponement for non-trading days and certain market disruption events. Even if the value of the underlier appreciates prior to the observation date but then drops by the observation date, the payment at maturity may be less, and may be significantly less, than it would have been had the payment at maturity been linked to the value of the underlier prior to such drop. Although the actual value of the underlier on the stated maturity date or at other times during the term of the securities may be higher than the closing level of the underlier on the observation date, the payment at maturity will be based solely on the closing level of the underlier on the observation date.

View Full Filing

View this 424B2 filing on SEC EDGAR